Last updated on June 2009

Pilot Study to Evaluate the Safety and Efficacy of Treatment With ORA102 Combined With Avastin (Bevacizumab) Versus Avastin Alone in Patients With Neovascular Age Related Macular Degeneration (AMD)

Brief description of study

This is s randomized, multi-center, double blind, 3 arm, phase I/II pilot study to evaluate the safety and efficacy of treatment with ORA102 combined with Avastin (Bevacizumab) versus Avastin alone, in patients with neo-vascular age related macular degeneration (AMD).

Clinical Study Identifier: NCT00745511

Contact Investigators or Research Sites near you

Start Over

Yossi Israeli

Barzilai Medical Center
Ashkelon, Israel
  Connect »

Yossi Israeli

Carmel Medical Center
Haifa, Israel
  Connect »

Itay Chovers, MD

Hadassah Medical center Israel
Jerusalem, Israel
  Connect »

Yossi Israeli

Tel-Aviv Sourasky Medical Center
Tel-Aviv, Israel
  Connect »

Yossi Israeli

Ziv Medical Center
Zefat, Israel
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.